{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T17:46:42Z","timestamp":1781372802589,"version":"3.54.1"},"reference-count":108,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Interstitial lung disease (ILD) is a severe and frequent extraglandular manifestation of primary Sj\u00f6gren\u2019s disease (pSjD), conferring significant morbidity and mortality. This narrative review synthesizes current evidence on the epidemiology, pathogenesis, clinical phenotypes, diagnosis, and management of pSjD-ILD, with a focus on phenotype-stratified care and evidence limitations. Key risk factors include anti-Ro52 antibody seropositivity, advanced age, and male sex. Diagnosis relies on a multidisciplinary approach integrating clinical assessment, serology, high-resolution computed tomography (predominantly fibrotic nonspecific interstitial pneumonia pattern), and pulmonary function tests. Pathogenesis involves a complex interplay of autoantibody-mediated damage, immune cell dysregulation, and dysbalanced pro-fibrotic signaling. We emphasize a phenotype-stratified treatment strategy: immunosuppression forms the cornerstone for inflammatory-predominant disease, while antifibrotic agents are pivotal for progressive fibrotic phenotypes. Critical limitations of current evidence include the extrapolation of most therapeutic data from other connective tissue disease-associated ILDs (CTD-ILDs) and a lack of pSjD-ILD-specific randomized controlled trials (RCTs). Emerging therapies, including rituximab and nintedanib, show promise but require further validation in pSjD-ILD cohorts. This review provides a pragmatic clinical framework to guide diagnosis, risk stratification, and individualized management, while highlighting critical unmet needs for future research, such as validated prognostic scores and pSjD-ILD-specific clinical trials.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1806321","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T05:40:05Z","timestamp":1776145205000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical features, diagnosis, and treatment of primary Sj\u00f6gren\u2019s disease with interstitial lung disease: A narrative review"],"prefix":"10.3389","volume":"17","author":[{"given":"Runzhi","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Immunology, Shaanxi Provincial People\u2019s Hospital","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Zhi","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Shaanxi Provincial People\u2019s Hospital","place":["Xi\u2019an, Shaanxi, China"]},{"name":"Department of Rheumatology and Immunology, Xi\u2019an Medical University","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanfang","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Shaanxi Provincial People\u2019s Hospital","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Shaanxi Provincial People\u2019s Hospital","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqing","family":"Xin","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Shaanxi Provincial People\u2019s Hospital","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Shaanxi Provincial People\u2019s Hospital","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Shaanxi Provincial People\u2019s Hospital","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2019.102447","article-title":"Clinical, morphological features and prognostic factors associated with interstitial lung disease in primary Sj\u00f6gren's syndrome: a systematic review from the Italian Society of Rheumatology","volume":"19","author":"Sambataro","year":"2020","journal-title":"Autoimmun Rev"},{"key":"B2","article-title":"Anti-Ro52 and\/or anti-Ro60 immune reactivity: autoantibody and disease associations","volume":"38","author":"Zampeli","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1804598","article-title":"Primary sj\u00f6gren\u2019s syndrome","volume":"379","author":"Henkin","year":"2018","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"16047","DOI":"10.1038\/nrdp.2016.47","article-title":"Sj\u00f6gren syndrome","volume":"2","author":"Brito-Zer\u00f3n","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21956","article-title":"Pain severity and neuropathic pain symptoms in primary Sj\u00f6gren's syndrome: a comparison study of seropositive and seronegative Sj\u00f6gren's syndrome patients","volume":"65","author":"Segal","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.703079","article-title":"Understanding fatigue in Sj\u00f6gren's syndrome: outcome measures, biomarkers and possible interventions","volume":"12","author":"M\u00e6land","year":"2021","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.770422","article-title":"The experiences of functioning and health of patients with primary Sj\u00f6gren's syndrome: a multicenter qualitative European study","volume":"8","author":"Unger","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-023-01057-6","article-title":"Epidemiology of sj\u00f6gren syndrome","volume":"20","author":"Beydon","year":"2024","journal-title":"Nat Rev Rheumatol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3899\/jrheum.190768","article-title":"Ocular manifestations in rheumatoid arthritis, connective tissue disease, and vasculitis: a systematic review and metaanalysis","volume":"48","author":"Turk","year":"2021","journal-title":"J Rheumatol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-042127","article-title":"Childhood-onset Sj\u00f6gren syndrome presenting as pulmonary hemorrhage","volume":"148","author":"Wang","year":"2021","journal-title":"Pediatrics"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1378\/chest.15-1539","article-title":"Amyloid-associated cystic lung disease","volume":"149","author":"Zamora","year":"2016","journal-title":"Chest"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev200","article-title":"Characterization of systemic disease in primary Sj\u00f6gren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements","volume":"54","author":"Ramos-Casals","year":"2015","journal-title":"Rheumatol (Oxford)"},{"key":"B13","first-page":"291","article-title":"Interstitial lung disease in Sj\u00f6gren's syndrome: a clinical review","volume":"38","author":"Luppi","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1177\/1759720x211020179","article-title":"Ten-year survival analysis of patients with primary Sj\u00f6gren's syndrome in China: a national prospective cohort study","volume":"13","author":"Qian","year":"2021","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2020.105895","article-title":"Anti-Ro52 antibodies are a risk factor for interstitial lung disease in primary Sj\u00f6gren syndrome","volume":"163","author":"Buvry","year":"2020","journal-title":"Respir Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1177\/1759720x211037519","article-title":"Natural history and screening of interstitial lung disease in systemic autoimmune rheumatic disorders","volume":"13","author":"Panagopoulos","year":"2021","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0047-2018","article-title":"Interstitial pneumonia with autoimmune features: a new classification still on the move","volume":"27","author":"Cavagna","year":"2018","journal-title":"Eur Respir Rev"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01327","article-title":"Pulmonary manifestations of primary Sj\u00f6gren's syndrome: underlying immunological mechanisms, clinical presentation, and management","volume":"10","author":"Gupta","year":"2019","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0011-2016","article-title":"Pulmonary manifestations of Sj\u00f6gren's syndrome","volume":"25","author":"Flament","year":"2016","journal-title":"Eur Respir Rev"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.00332","article-title":"Lung involvement in primary Sj\u00f6gren's syndrome-an under-diagnosed entity","volume":"7","author":"Sogkas","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1159\/000530785","article-title":"Clinical presentation of connective tissue disease patients with and without interstitial lung disease: a retrospective study","volume":"102","author":"Sambataro","year":"2023","journal-title":"Respiration"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0021-2020","article-title":"Lung complications of Sjogren syndrome","volume":"29","author":"Luppi","year":"2020","journal-title":"Eur Respir Rev"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-020-00383-w","article-title":"Connective tissue disease-related interstitial lung disease: prevalence, patterns, predictors, prognosis, and treatment","volume":"198","author":"Jeganathan","year":"2020","journal-title":"Lung"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10123291","article-title":"Delphi-based consensus on interstitial lung disease screening in patients with connective tissue diseases (Croatian national-based study)","volume":"10","author":"Radi\u0107","year":"2022","journal-title":"Biomedicines"},{"key":"B25","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.autrev.2016.09.017","article-title":"Interstitial lung disease in primary Sj\u00f6gren's syndrome","volume":"16","author":"Roca","year":"2017","journal-title":"Autoimmun Rev"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2021.105237","article-title":"Fibrosing interstitial lung disease in primary Sjogren syndrome","volume":"88","author":"Manfredi","year":"2021","journal-title":"Joint Bone Spine"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/b4z1qu","article-title":"Distinct clinical phenotypes of primary Sj\u00f6gren's syndrome differ by onset age: a retrospective study of 742 cases and review of the literature","volume":"40","author":"Luo","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2021.1965205","article-title":"Clinical profiles of SS-ILD compared with SS-NILD in a Chinese population: a retrospective analysis of 735 patients","volume":"53","author":"Guo","year":"2021","journal-title":"Ann Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2021.105132","article-title":"Elderly-onset primary Sj\u00f6gren's syndrome focused on clinical and salivary gland ultrasonographic features","volume":"88","author":"Lee","year":"2021","journal-title":"Joint Bone Spine"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-021-08911-z","article-title":"Anti-Ro52 autoantibody is common in systemic autoimmune rheumatic diseases and correlating with worse outcome when associated with interstitial lung disease in systemic sclerosis and autoimmune myositis","volume":"63","author":"Chan","year":"2022","journal-title":"Clin Rev Allergy Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13075-022-02811-z","article-title":"Circulating Th2 cell reduction and Th1\/Th2 imbalance are correlated with primary Sjogren's syndrome-associated interstitial lung disease","volume":"24","author":"Shi","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev300","article-title":"Associations between anti-Ro52 antibodies and lung fibrosis in mixed connective tissue disease","volume":"55","author":"Gunnarsson","year":"2016","journal-title":"Rheumatol (Oxford)"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/194864","article-title":"Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectives","volume":"2015","author":"Lopalco","year":"2015","journal-title":"Mediators Inflammation"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024097","article-title":"P2X7 receptor and caspase 1 activation are central to airway inflammation observed after exposure to tobacco smoke","volume":"6","author":"Eltom","year":"2011","journal-title":"PloS One"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2010080798","article-title":"The inflammasomes in kidney disease","volume":"22","author":"Anders","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2279","article-title":"The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance","volume":"17","author":"Vandanmagsar","year":"2011","journal-title":"Nat Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaf198","article-title":"T cells of patients with systemic sclerosis or Sj\u00f6gren's disease display an aberrant metabolic state and memory phenotype in blood and lungs","volume":"64","author":"Ehlers","year":"2025","journal-title":"Rheumatol (Oxford)"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70297","article-title":"Sj\u00f6gren's syndrome: epidemiology, classification criteria, molecular pathogenesis, diagnosis, and treatment","volume":"6","author":"Hu","year":"2025","journal-title":"MedComm (2020)"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct Target Ther"},{"key":"B40","doi-asserted-by":"publisher","first-page":"9195157","DOI":"10.1136\/annrheumdis-2023-eular.639","article-title":"Clinical significance of different profiles of anti-Ro antibodies in connective tissue diseases","volume":"2023","author":"Yang","year":"2023","journal-title":"J Immunol Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1089\/omi.2022.0138","article-title":"Drug repositioning identifies six drug candidates for systemic autoimmune diseases by integrative analyses of transcriptomes from scleroderma, systemic lupus erythematosus, and Sjogren's syndrome","volume":"26","author":"Oktem","year":"2022","journal-title":"Omics"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1039\/c5mb00101c","article-title":"The PI3K\/AKT\/mTOR interactive pathway","volume":"11","author":"Ersahin","year":"2015","journal-title":"Mol Biosyst"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.07.029","article-title":"The PI3K pathway in human disease","volume":"170","author":"Fruman","year":"2017","journal-title":"Cell"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26125867","article-title":"The role of anti-SSB\/La antibodies as predictors of decreased diffusing capacity of the lungs for carbon monoxide (DLCO) in primary Sj\u00f6gren disease","volume":"26","author":"Caraiola","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2024-221495","article-title":"IgG and plasma viscosity as markers of disease activity in primary Sjogren's syndrome-related lymphocytic interstitial pneumonia","volume":"79","author":"Alawi","year":"2024","journal-title":"Thorax"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2021.102661","article-title":"Antigen-driven autoantibody production in lungs of interstitial lung disease with autoimmune disease","volume":"121","author":"Takeshita","year":"2021","journal-title":"J Autoimmun"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1462242","article-title":"Quantification of autoantibodies using a luminescent profiling method in autoimmune interstitial lung disease","volume":"15","author":"Burbelo","year":"2024","journal-title":"Front Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jid.2021.11.031","article-title":"Type I interferons in autoimmunity","volume":"142","author":"Fernandez-Ruiz","year":"2022","journal-title":"J Invest Dermatol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kew431","article-title":"Type I interferon-mediated autoimmune diseases: pathogenesis, diagnosis and targeted therapy","volume":"56","author":"Psarras","year":"2017","journal-title":"Rheumatol (Oxford)"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1002\/art.41610","article-title":"Integrative analysis reveals a molecular stratification of systemic autoimmune diseases","volume":"73","author":"Barturen","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"B51","article-title":"Rituximab therapy in primary Sj\u00f6gren's syndrome with interstitial lung disease: a retrospective cohort study","volume":"34","author":"Chen","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2019.102453","article-title":"Targeting CD20 in the treatment of interstitial lung diseases related to connective tissue diseases: a systematic review","volume":"19","author":"Bellan","year":"2020","journal-title":"Autoimmun Rev"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2024.06.017","article-title":"Kynurenine acts as a signaling molecule to attenuate pulmonary fibrosis by enhancing the AHR-PTEN axis","volume":"71","author":"Wang","year":"2025","journal-title":"J Adv Res"},{"key":"B54","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.medj.2022.05.002","article-title":"Cross-tissue, single-cell stromal atlas identifies shared pathological fibroblast phenotypes in four chronic inflammatory diseases","volume":"3","author":"Korsunsky","year":"2022","journal-title":"Med"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-020-00623-6","article-title":"Angiopoietin-like protein 2 as a novel marker for patients with primary Sjogren's syndrome-related interstitial lung disease","volume":"20","author":"Shi","year":"2020","journal-title":"Clin Exp Med"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2023.103050","article-title":"Compositional and functional aberrance of the gut microbiota in treatment-na\u00efve patients with primary Sj\u00f6gren's syndrome","volume":"141","author":"Jia","year":"2023","journal-title":"J Autoimmun"},{"key":"B57","first-page":"94","article-title":"Prevalence and spectrum of symptomatic pulmonary involvement in primary Sj\u00f6gren's syndrome","volume":"36","author":"Kampolis","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/7bylp2","article-title":"Glandular involvement in primary Sj\u00f6gren's syndrome patients with interstitial lung disease-onset and sicca-onset, a single centre cross-sectional study","volume":"40","author":"La Rocca","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.20452\/pamw.16394","article-title":"Pulmonary fibrosis in primary Sj\u00f6gren syndrome: computed tomography, clinical features, and associated clinical factors","volume":"133","author":"Li","year":"2023","journal-title":"Pol Arch Intern Med"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1400319","article-title":"Defective selection of thymic regulatory T cells accompanies autoimmunity and pulmonary infiltrates in Tcra-deficient mice double transgenic for human La\/Sj\u00f6gren's syndrome-B and human La-specific TCR","volume":"194","author":"Yaciuk","year":"2015","journal-title":"J Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2024.08.008","article-title":"Diffuse cystic lung disease as the presenting manifestation of Sj\u00f6gren syndrome","volume":"13","author":"Gupta","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"B62","doi-asserted-by":"publisher","first-page":"9189","DOI":"10.1038\/s41598-023-35608-4","article-title":"Clinical course and risk factors for development and progression of interstitial lung disease in primary Sj\u00f6gren's syndrome","volume":"13","author":"Lee","year":"2023","journal-title":"Sci Rep"},{"key":"B63","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s13075-017-1409-7","article-title":"Usefulness of lung ultrasound B-lines in connective tissue disease-associated interstitial lung disease: a literature review","volume":"19","author":"Wang","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2024.105820","article-title":"Pleural irregularities: a new ultrasound marker for lung involvement in primary Sj\u00f6gren's disease","volume":"92","author":"Ferro","year":"2025","journal-title":"Joint Bone Spine"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-016-1582-8","article-title":"Assessment of interstitial lung disease in Sj\u00f6gren's syndrome by lung ultrasound: a pilot study of correlation with high-resolution chest tomography","volume":"12","author":"Vasco","year":"2017","journal-title":"Intern Emerg Med"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2020.109030","article-title":"Quantitative analysis of Sjogren's syndrome related interstitial lung disease with different methods","volume":"128","author":"Ufuk","year":"2020","journal-title":"Eur J Radiol"},{"key":"B67","article-title":"The use of ultrasound for assessing interstitial lung involvement in connective tissue diseases","volume":"36","author":"Ferro","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2019.105811","article-title":"Prognostic factors for primary Sj\u00f6gren's syndrome-associated interstitial lung diseases","volume":"159","author":"Kamiya","year":"2019","journal-title":"Respir Med"},{"key":"B69","doi-asserted-by":"publisher","first-page":"12827","DOI":"10.1038\/s41598-021-92024-2","article-title":"Long-term clinical course and outcome in patients with primary Sj\u00f6gren syndrome-associated interstitial lung disease","volume":"11","author":"Kim","year":"2021","journal-title":"Sci Rep"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.998028","article-title":"Radiological patterns and pulmonary function values of lung involvement in primary Sj\u00f6gren's syndrome: a pilot analysis","volume":"9","author":"Mormile","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00150314","article-title":"An official European Respiratory Society\/American Thoracic Society technical standard: field walking tests in chronic respiratory disease","volume":"44","author":"Holland","year":"2014","journal-title":"Eur Respir J"},{"key":"B72","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ard.2025.08.021","article-title":"ERS\/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease developed by the task force for connective tissue disease-associated interstitial lung disease of the European Respiratory Society (ERS) and the European Alliance of Associations for Rheumatology (EULAR) endorsed by the European Reference Network on rare respiratory diseases (ERN-LUNG)","volume":"85","author":"Antoniou","year":"2026","journal-title":"Ann Rheum Dis"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0087-2022","article-title":"The 6-min walk test as a primary end-point in interstitial lung disease","volume":"31","author":"Harari","year":"2022","journal-title":"Eur Respir Rev"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2025.133185","article-title":"Sj\u00f6gren's syndrome and pulmonary hypertension: exploring the intricate link with interstitial lung disease","volume":"430","author":"Coppi","year":"2025","journal-title":"Int J Cardiol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2025.01.006","article-title":"Guidelines for the echocardiographic assessment of the right heart in adults and special considerations in pulmonary hypertension: recommendations from the American Society of Echocardiography","volume":"38","author":"Mukherjee","year":"2025","journal-title":"J Am Soc Echocardiogr"},{"key":"B76","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s40001-022-00828-3","article-title":"Biomarkers of interstitial lung disease associated with primary Sj\u00f6gren's syndrome","volume":"27","author":"Weng","year":"2022","journal-title":"Eur J Med Res"},{"key":"B77","doi-asserted-by":"publisher","first-page":"5343","DOI":"10.1038\/s41598-022-09283-w","article-title":"Blood KL-6 predicts prognosis in primary Sj\u00f6gren's syndrome-associated interstitial lung disease","volume":"12","author":"Kim","year":"2022","journal-title":"Sci Rep"},{"key":"B78","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s10238-025-01779-9","article-title":"Dynamics of serum tumor markers may indicate the progression of interstitial lung disease in Sj\u00f6gren's syndrome patients: new roles for old friends","volume":"25","author":"Song","year":"2025","journal-title":"Clin Exp Med"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.987723","article-title":"Serum MUC5AC protein levels are correlated with the development and severity of connective tissue disease-associated pulmonary interstitial lesions","volume":"13","author":"Weng","year":"2022","journal-title":"Front Immunol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.molimm.2024.02.008","article-title":"Predicting the risk of interstitial lung disease in patients with primary Sj\u00f6gren's syndrome: novel nomogram and elevated Th2 cells","volume":"168","author":"Wang","year":"2024","journal-title":"Mol Immunol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics10040208","article-title":"Patients with interstitial lung disease secondary to autoimmune diseases: how to recognize them","volume":"10","author":"Sambataro","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2024.1448946","article-title":"Serum biomarker-based risk model construction for primary Sj\u00f6gren's syndrome with interstitial lung disease","volume":"11","author":"Liu","year":"2024","journal-title":"Front Mol Biosci"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.diii.2024.01.003","article-title":"Lung fibrosis is uncommon in primary Sj\u00f6gren's disease: a retrospective analysis of computed tomography features in 77 patients","volume":"105","author":"de Fr\u00e9mont","year":"2024","journal-title":"Diagn Interv Imaging"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1002\/acr.25347","article-title":"2023 American College of Rheumatology (ACR)\/American College of Chest Physicians (CHEST) guideline for the screening and monitoring of interstitial lung disease in people with systemic autoimmune rheumatic diseases","volume":"76","author":"Johnson","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2021.106405","article-title":"Occult primary Sj\u00f6gren syndrome in patients with interstitial pneumonia with autoimmune features","volume":"182","author":"Auteri","year":"2021","journal-title":"Respir Med"},{"key":"B86","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.rmed.2018.02.023","article-title":"Lymphocytic focus score is positively related to airway and interstitial lung diseases in primary Sj\u00f6gren's syndrome","volume":"137","author":"Kakugawa","year":"2018","journal-title":"Respir Med"},{"key":"B87","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1080\/1744666x.2018.1411190","article-title":"Interstitial lung disease in systemic autoimmune rheumatic diseases: a comprehensive review","volume":"14","author":"Atzeni","year":"2018","journal-title":"Expert Rev Clin Immunol"},{"key":"B88","article-title":"Autoimmune epithelitis beyond the exocrine glands: an unusual case of anti-Ro\/La and Scl-70 lymphocytic interstitial pneumonia","volume":"37","author":"Argyropoulou","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/9t3ul2","article-title":"Chest high-resolution computed tomography in primary Sj\u00f6gren's syndrome: an up-to-date primer for rheumatologists","volume":"40","author":"Cereser","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1177\/0885066613516579","article-title":"Proceedings of the American College of Rheumatology\/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: a multidisciplinary approach to address challenges and opportunities","volume":"71","author":"Fischer","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.ard.2025.08.021","article-title":"ERS\/EULAR clinical practice guidelines for connective tissue diseases associated interstitial lung disease","author":"Antoniou","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102742","article-title":"Targeted therapies in interstitial lung disease secondary to systemic autoimmune rheumatic disease. Current status and future development","volume":"20","author":"Karakontaki","year":"2021","journal-title":"Autoimmun Rev"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1111\/resp.13365","article-title":"Multidimensional improvement in connective tissue disease-associated interstitial lung disease: two courses of pulse dose methylprednisolone followed by low-dose prednisone and tacrolimus","volume":"23","author":"Yamano","year":"2018","journal-title":"Respirology"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h6819","article-title":"Management of interstitial lung disease associated with connective tissue disease","volume":"352","author":"Mathai","year":"2016","journal-title":"Bmj"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2017.08.469","article-title":"Cyclophosphamide for connective tissue disease-associated interstitial lung disease","volume":"1","author":"Barnes","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1159\/000441238","article-title":"Treatment considerations of lung involvement in rheumatologic disease","volume":"90","author":"Robles-Perez","year":"2015","journal-title":"Respiration"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2017.12.010","article-title":"Sj\u00f6gren syndrome with associated lymphocytic interstitial pneumonia successfully treated with tacrolimus and abatacept as an alternative to rituximab","volume":"153","author":"Thompson","year":"2018","journal-title":"Chest"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2020.1764931","article-title":"Rationale for and clinical development of anti-fractalkine antibody in rheumatic diseases","volume":"20","author":"Muraoka","year":"2020","journal-title":"Expert Opin Biol Ther"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa032534","article-title":"Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis","volume":"350","author":"Edwards","year":"2004","journal-title":"N Engl J Med"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2020.10.011","article-title":"Consensus guidelines for evaluation and management of pulmonary disease in Sj\u00f6gren's","volume":"159","author":"Lee","year":"2021","journal-title":"Chest"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1097\/mcp.0000000000000791","article-title":"The other connective tissue disease-associated interstitial lung diseases: Sjogren's syndrome, mixed connective tissue disease, and systemic lupus erythematosus","volume":"27","author":"Lee","year":"2021","journal-title":"Curr Opin Pulm Med"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217230","article-title":"Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs)","volume":"80","author":"Spagnolo","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.151322","article-title":"An open-label, phase II study of the safety and tolerability of pirfenidone in patients with scleroderma-associated interstitial lung disease: the LOTUSS trial","volume":"43","author":"Khanna","year":"2016","journal-title":"J Rheumatol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201706-1301oc","article-title":"Nintedanib with add-on pirfenidone in idiopathic pulmonary fibrosis. Results of the INJOURNEY trial","volume":"197","author":"Vancheri","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"B105","doi-asserted-by":"publisher","first-page":"17842","DOI":"10.4046\/trd.2006.61.4.321","article-title":"Malnutrition is associated with mortality in Sj\u00f6gren's syndrome-associated interstitial lung disease","volume":"14","author":"Chung","year":"2024","journal-title":"Sci Rep"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-eular.3564","article-title":"Long-term survival of lung transplantation for interstitial lung disease associated with connective tissue diseases: a study of 26 cases from a referral centre","volume":"38","author":"Prieto-Pe\u00f1a","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab364","article-title":"Mortality in patients with primary Sj\u00f6gren's syndrome: a systematic review and meta-analysis","volume":"60","author":"Huang","year":"2021","journal-title":"Rheumatol (Oxford)"},{"key":"B108","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12931-017-0653-3","article-title":"Increased activated regulatory T cells proportion correlate with the severity of idiopathic pulmonary fibrosis","volume":"18","author":"Hou","year":"2017","journal-title":"Respir Res"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1806321\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T05:40:07Z","timestamp":1776145207000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1806321\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":108,"alternative-id":["10.3389\/fimmu.2026.1806321"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1806321","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]},"article-number":"1806321"}}